Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps ...

Although Paxlovid did not demonstrate widespread efficacy, a novel approach to long COVID research has emerged.

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

A newly released report reveals seven U.S. military athletes showed COVID-19 symptoms after the 2019 Military World Games in ...

While the Trump administration is focused on cutting costs, addressing the gaps in care for millions of Americans with ...

Recent studies reveal that children and adolescents who contracted COVID-19 face increased risks of long-term health problems. These include kidney, gastrointestinal, and cardiovascular issues, ...

Long COVID can result in increased risk for a variety of serious health problems for young people, including those affecting ...

WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current antivirals like Paxlovid. WEHI researchers have developed a drug compound that ...

The economic burden of long COVID may exceed $2 billion and reach nearly $31 billion when symptoms last between 1 and 3 years, and researchers say these numbers will likely continue to grow as ...

The White House has thrown its weight behind the lab leak theory, an idea that has divided intelligence agencies.

Five years after the pandemic’s start, millions of Americans are still struggling with long-lasting symptoms of Covid-19. Cognitive difficulties are among the most troubling and common symptoms ...